My Canadian Pharmacy Generic Levaquin
Levaquin peritonitis, impetigo, abscesses of the skin, furuncle and carbuncle, unspecified abscesses, pyoderma, unspecified local infection of skin and subcutaneous tissue, acute tubulointerstitial nephritis, urinary tract infection with unspecified localization, chronic prostatitis, bacteremia
Levaquin is an antibiotic used extensively in the treatment of systemic infections. It belongs to the class of fluoroquinolones. This powerful antibiotic is used to eliminate bacteria causing infections of lungs (pneumonia, bronchitis), bladder, skin, prostate, and kidneys. Your practitioner, however, may administer this medicine for other purposes not listed in this guide.
Levaquin: drug description
Levaquin has a broad spectrum of action. The drug inhibits bacterial topoisomerase IV and DNAase (topoisomerase type II) – the enzymes responsible for replication, transcription, repair and recombination of bacterial DNA. At concentrations equivalent to or somewhat higher than inhibitory concentrations, Levaquin often has a bactericidal effect. Resistance to levofloxacin, resulting from spontaneous mutations, in vitro is seldom manifested.
How to use Levaquin
Levofloxacin tablets should be taken orally between or before meals. The daily dosage may be divided into two doses. The tablets can be chewed. Drink 0.5-1 cups of water to wash down the pill.
The scheme of the drug dosage administration depends on the severity of the disease, the sensitivity of micro-organisms and the flow of the pathological process. When receiving the drug you should follow the rule that apply to all antibacterial agents: the pill therapy should be continued after the elimination of reliable agent or not less than 48-72 hours after normalization of body temperature.
Ssafety and efficacy of the drug in persons under the age of 18 are not defined. You should bear in mind that levofloxacin causes arthropathy and osteochondrosis in young growing animals of different species. Levaquin is not used in patients with confirmed or suspected central nervous system disease, accompanied by a predisposition to seizures or lower the threshold of convulsive readiness (epilepsy, severe cerebral arteriosclerosis), in the presence of other risk factors for seizures or lower the threshold of convulsive readiness (concomitant use of certain drugs, renal failure), the simultaneous treatment with corticosteroids (increased risk of tendinitis), the lack of glucose-6-phosphate dehydrogenase (possible hemolysis).